Dilute sodium-hypochlorite baths added to standard care,
does it really help with Improved clinician-rated severity in moderate-to-severe atopic dermatitis?
research showsGrade C with 50 points. A direct 40-person water-bath crossover trial found no added bleach benefit and favored water on one affected-area measure. An eight-week study and a meta-analysis were more favorable, but ingredient-specific net effects, prespecification, and individual unpublished data were incompletely verified.
ads claimThe claim that bleach baths kill skin bacteria and treat eczema skips the null colonization result and uncertain infection evidence.
Useful facts when choosing a product
- This is not evidence for putting undiluted household bleach on skin.
- Concentrations and product formulations are not interchangeable.
- Studies added the bath to rather than replaced standard topical care.
Chamgap Semantic Classification Code
Permanent code issued
P.dilute-bleach-bath.topical-bath.atopic-dermatitis-severity.reduce.water-bathProcedures, devices and tests > Dilute sodium-hypochlorite baths added to standard care > Topical bath > Improved clinician-rated severity in moderate-to-severe atopic dermatitis > Reduction claim > Water bath
Codex retrospectively verified the principal intervention, delivery, population, endpoint, and comparator from the existing reviewed verdict and issued a permanent semantic code. Secondary outcomes on the page are not transferred as separate claims. The code identifies the intervention and claim; it never contains the evidence grade, score, or safety result.
Exact Claim Classification
These independent facets prevent evidence from different forms, routes, populations, effects, and comparators from being mixed.
| Intervention class | P · Procedure, surgery, device, or test |
|---|---|
| Canonical ingredient or intervention | Dilute sodium-hypochlorite baths added to standard care |
| Source or part used | Plant source not applicable; specified device or procedure |
| Formulation or processing | Dilute sodium-hypochlorite baths added to standard care |
| Route | Topical bath |
| Dose | Dilute sodium-hypochlorite baths added to standard care |
| Duration | Four weeks per period in the principal crossover trial |
| Population | 40 completed; 14 nonadherent |
| Effect or condition | Improved clinician-rated severity in moderate-to-severe atopic dermatitis |
| Primary endpoint | SCORAD, affected area, and topical medication use |
| Comparator | Water bath |
| Duplicate-detection key | dilute-bleach-bath|topical-bath|40 completed; 14 nonadherent|atopic-dermatitis-severity|Four weeks per period in the principal crossover trial |
What the research actually shows
Very dilute hypochlorite baths were compared with water baths or usual care while emollients and topical treatments continued. Trials that simultaneously changed antibiotics were not treated as bleach-only evidence.
Why this is classified as C (50)
The publicly funded water-controlled study is a strength, but its direct results were null or water-favoring and positive evidence has incomplete prespecification, net effects, and co-treatment attribution, giving C with 50 points.
Counterpoint. The colonization RR interval included 1, and clinical infection reduction was not established.
Rejudgment record. Cross-check applied — Separated common water-bath effects from added bleach effects and graded EASI, patient reports, infections, and colonization separately; unpublished source data did not earn strengths
| Endpoint | P | Symptom or function itself is the target - including patient reports and performance tests |
| Replication | R0 | Trials conflict in direction |
| Independence | I2 | Decisive evidence is publicly or non-profit funded |
| Effect size | EX | The clinical size of the effect could not be judged |
| Precision | CX | No pooled confidence interval could be confirmed |
Stored derived and displayed grades match; this is not a current recalculation or validity check (C).
Sub-claim grades by effect
This ingredient is marketed for several effects. A single overall grade blends strong and weak claims together, so each effect is graded separately here. The overall grade reflects the strongest disconfirming or core claim.
| Effect (sub-claim) | Grade | Basis |
|---|---|---|
| Improved clinician-rated atopic-dermatitis severity | C | A small pooled EASI signal coexists with a null water-controlled trial. |
| Improved itch, sleep, or quality of life | D | Patient-centered outcomes were sparse or uncertain. |
| Reduced S. aureus colonization or infection | D | The colonization RR was null and clinical infection benefit was unestablished. |
Cross-check — AI research and Codex final gate
Evidence Table
| Study | Design | Sample | Funding | Endpoint | Result | Weight |
|---|---|---|---|---|---|---|
| Hon KL et al. 2016 | Double-blind randomized bleach-versus-water crossover trial | 40 completed; 14 nonadherent | Specific funding and conflicts unverified | SCORAD, affected area, and topical medication use | No added bleach benefit by ITT; affected-area SCORAD change favored water, -5.7±15.4 versus 0.6±12.4, P=.03 | Key same-water control |
| Bakaa L et al. 2022 | Systematic review and Bayesian meta-analysis | 10 randomized trials and 307 participants | Academic/public investigators; no specific manufacturer support reported | EASI-50 and EASI, colonization, patient reports, and adverse events | EASI-50 22% versus 32%; ratio of means 0.78 (95% CrI 0.59-0.99); colonization RR 0.89 (0.73-1.09) | Overall evidence synthesis |
Receipt — 3 References
All 3 cited sources were verified for existence at the original page (as of 2026-09-07).
Final verification and publication gate: Codex · Evidence date: 2026-09-07 · Corrections: none
Cite this verdict
[Chamgap] Dilute Bleach Baths for Atopic Dermatitis—A Small EASI Signal With Uncertain Water-Control and Infection Benefits — Evidence Grade C·50. 3 cited sources checked. Source: https://chamgap.com/en/verdicts/skin-hair/dilute-bleach-bath-atopic-dermatitis-water-control/ · CC BY 4.0CC BY 4.0 — free to use with attribution; do not distort grades, numbers, or verdict meaning.
What this document does and does not do
Chamgap is an information source. It reports what research has and has not confirmed; it does not tell readers what to take or buy. That decision belongs to readers and, when needed, medical or legal professionals. This verdict reflects literature available up to the search date and may change as new research appears. Nothing here is medical advice.